Stocks and Investing Stocks and Investing
Wed, January 4, 2023
Tue, January 3, 2023

Derek Archila Downgraded (APLS) to Hold and Held Target at $58 on, Jan 3rd, 2023


Published on 2024-10-28 00:43:01 - WOPRAI, Derek Archila
  Print publication without navigation


Derek Archila of Wells Fargo, Downgraded "Apellis Pharmaceuticals, Inc." (APLS) to Hold and Held Target at $58 on, Jan 3rd, 2023.

Derek has made no other calls on APLS in the last 4 months.



There are 6 other peers that have a rating on APLS. Out of the 6 peers that are also analyzing APLS, 3 agree with Derek's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Chris Howerton of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $40 on, Thursday, November 10th, 2022
  • Tiago Fauth of "Credit Suisse" Maintained at Hold with Decreased Target to $43 on, Tuesday, November 8th, 2022
  • Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $67 on, Monday, September 12th, 2022


These are the ratings of the 3 analyists that currently disagree with Derek


  • Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $79 on, Tuesday, November 15th, 2022
  • Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Increased Target to $123 on, Tuesday, October 18th, 2022
  • Annabel Samimy of "Stifel" Maintained at Strong Buy with Increased Target to $65 on, Thursday, September 8th, 2022
Contributing Sources